홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Trimethylaluminum → HCID 178489760, 화합물

HRID 1911421
인쇄

반응식

HRID 1911421 반응식
[N:1]1([C:8]2[CH:18]=[CH:17][C:11]([C:12]([O:14]CC)=O)=[CH:10][CH:9]=2)[CH2:7][CH2:6][CH2:5][NH:4][CH2:3][CH2:2]1.[CH3:19][O:20][C:21]1[CH:22]=[C:23]([CH2:29][CH2:30][C:31]2[CH:32]=[C:33]([NH2:36])[NH:34][N:35]=2)[CH:24]=[C:25]([O:27][CH3:28])[CH:26]=1.C[Al](C)C>C1(C)C=CC=CC=1>[N:1]1([C:8]2[CH:9]=[CH:10][C:11]([C:12]([NH:36][C:33]3[NH:34][N:35]=[C:31]([CH2:30][CH2:29][C:23]4[CH:24]=[C:25]([O:27][CH3:28])[CH:26]=[C:21]([O:20][CH3:19])[CH:22]=4)[CH:32]=3)=[O:14])=[CH:17][CH:18]=2)[CH2:7][CH2:6][CH2:5][NH:4][CH2:3][CH2:2]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 16682925TrimethylaluminumHCID 18425301Ethyl 4-(1,4-diazepan-1-yl)benzoateHCID 178489815HCID 178489815, 화합물

생성물 1

HCID 178489760HCID 178489760, 화합물수율 2.7%

시약·촉매·용매 1

HCID 1140Toluene용매

실험 절차

4-(1,4-diazepan-1-yl)-N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]benzamide was prepared following the procedure as outlined for Example 99, starting from ethyl 4-(1,4-diazepan-1-yl)benzoate (0.497 g, 2 mmol) and 5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-amine (0.495 g, 2.00 mmol) and 2M trimethylaluminium (2.50 mL, 5.0 mmol) in toluene (10 ml). The crude product was purified by silica column chromatography, eluting with a gradient of 0 to 10% 2.5 M ammonia MeOH in DCM. Fractions containing the product were evaporated to dryness and further purified by preparative HPLC, using decreasingly polar mixtures of water (containing 1% NH3) and MeCN as eluents. Fractions containing the desired compound were evaporated to dryness to afford the title compound (0.024 g, 2.67%) as a white solid.

후처리

  1. custom4-(1,4-diazepan-1-yl)-N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]benzamide was prepared
  2. customThe crude product was purified by silica column chromatography
  3. washeluting with a gradient of 0 to 10% 2.5 M ammonia MeOH in DCM
  4. additionFractions containing the product
  5. customwere evaporated to dryness
  6. customfurther purified by preparative HPLC
  7. additionFractions containing the desired compound
  8. customwere evaporated to dryness

출처 및 근거

ORD 기록
ord-9c728a501340436faded9f9a51548025
출처 데이터셋
uspto-grants-2013_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08604022B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트